Posted On: 05/25/2016 3:15:27 PM
Post# of 72443
Re: scottsmith #23000
It's funny that you didn't bold the word "mild". More effective in moderate to severe psoriasis doesn't mean it's not effective in mild to moderate psoriasis.
Primary endpoint: Percentage of subjects with ≥ 2 point improvement in IGA rating in patients with mild to moderate chronic plaque psoriasis.
PR: Cellceutix Phase 2 Trial of Prurisol for Mild to Moderate Psoriasis Meets Primary Endpoint
Please explain why the trial failed.
Primary endpoint: Percentage of subjects with ≥ 2 point improvement in IGA rating in patients with mild to moderate chronic plaque psoriasis.
PR: Cellceutix Phase 2 Trial of Prurisol for Mild to Moderate Psoriasis Meets Primary Endpoint
Please explain why the trial failed.
(1)
(0)
Scroll down for more posts ▼
